ClinicalTrials.Veeva

Menu

Evaluation of the Effectiveness of Prepectoral Breast Reconstruction

E

European Institute of Oncology

Status

Active, not recruiting

Conditions

Breast Cancer

Treatments

Procedure: Submuscolar reconstruction
Procedure: Prepectoral reconstruction

Study type

Interventional

Funder types

Other

Identifiers

NCT05125991
IEO 1002/

Details and patient eligibility

About

The study plans to compare conventional submuscular reconstruction with definitive implant and muscle sparing reconstruction with definitive implant in selected patients. The two techniques are compared in terms of patient quality of life and satisfaction; patient related outcomes, reconstruction morbidity, early and late complications are also investigated.

Full description

The study plans to compare conventional submuscular reconstruction with definitive implant and muscle sparing reconstruction with definitive implant in selected patients. The two techniques are compared in terms of patient quality of life and satisfaction; patient related outcomes, reconstruction morbidity, early and late complications are also investigated.

The study plans to collect robust data to support the prepectoral implant placement and complete coverage of implant with acellular dermal matrix in the clinical practice.

Consequently, the project plans to move toward evidence-based medicine in breast reconstruction, avoiding marketing influences and surgeon experience as the sole source of evidence.

Enrollment

58 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Informed consent
  2. Not smokers
  3. No vascular comorbidities (diabetic, vasculitis, coagulation disorders)
  4. BMI<30
  5. CUP B-C (or mastectomy estimated weight less than 550gm)
  6. Good subcutaneous layer (>1cm on pinch test measured in upper/medial quadrant)
  7. No previous breast surgery
  8. No previous breast irradiation
  9. Breast Ptosis 1-2 according to Renault's classification
  10. DCIS tumors
  11. T1 T2 pN0 breast tumor with known favourable biologic features

Exclusion criteria

  1. Impossibility of immediate reconstruction with definitive implants due to inadequacy of mastectomy flaps (inadequate in quantity and/or quality)
  2. Positive sentinel node biopsy requiring complete axillary dissection

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

58 participants in 2 patient groups

Prepectoral reconstruction
Experimental group
Description:
Prepectoral breast reconstruction with Braxon dermal matrix
Treatment:
Procedure: Prepectoral reconstruction
Submuscular reconstruction
Active Comparator group
Description:
Submuscolar breast reconstruction
Treatment:
Procedure: Submuscolar reconstruction

Trial contacts and locations

1

Loading...

Central trial contact

Pietro Sala, MD; Francesca De Lorenzi, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems